Atlas Trials

Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary Thromboembolism

Clinical trial NCT05512702 · UNKNOWN

Trial details

NCT number
NCT05512702
Sponsor
Ege University
Status
UNKNOWN
Study type
OBSERVATIONAL
Pulmonary Embolism
Start date
2022-06-03
Primary completion
2023-06-03
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.